Patents Assigned to BioNTech Delivery Technologies GmbH
  • Patent number: 11541010
    Abstract: The invention concerns lipid assemblies, liposomes having an outer surface comprising a mixture of anionic and cationic moieties; wherein at least a portion of the cationic moieties are imino moieties that are essentially charged under physiological conditions, and their use for serum resistant transfection of cells.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: January 3, 2023
    Assignee: BioNTech Delivery Technologies GmbH
    Inventors: Steffen Panzner, Evgenios Siepi
  • Patent number: 10894962
    Abstract: The invention proves an oligonucleotide comprising one or more carboxylated 2?-amino-LNA nucleotide units. The invention also provides a method of transfecting cells with the oligonucleotide, a method of treating a human or animal by therapy using the oligonucleotide, and a pharmaceutical composition comprising the oligonucleotide.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: January 19, 2021
    Assignee: BIONTECH DELIVERY TECHNOLOGIES GMBH
    Inventor: Steffen Panzner
  • Publication number: 20200330384
    Abstract: The invention concerns lipid assemblies, liposomes having an outer surface comprising a mixture of anionic and cationic moieties; wherein at least a portion of the cationic moieties are imino moieties that are essentially charged under physiological conditions, and their use for serum resistant transfection of cells.
    Type: Application
    Filed: May 4, 2020
    Publication date: October 22, 2020
    Applicant: BioNTech Delivery Technologies GmbH
    Inventors: Steffen PANZNER, Evgenios SIEPI